Niki BioSolutions, Inc. Investing Cash Flow
Niki BioSolutions, Inc. (NIKI) reported Investing Cash Flow of $58.62 thousand for the 12-month period ending 2024-12-31, per its S-4/A filed 2026-05-11.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-05-11
- Niki BioSolutions, Inc. net cash provided by (used in) investing activities for the quarter ending 2024-12-31 was $0.00.
- Niki BioSolutions, Inc. net cash provided by (used in) investing activities for the quarter ending 2024-09-30 was $0.00.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 10 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: S-4/A 12 month − 6-K 9 month · filed 2026-05-11 | $0.00 derived: sum of 2 quarters · filed 2026-05-11 | $58.62K S-4/A · filed 2026-05-11 | ||
| 2024-09-30 | $0.00 derived: 6-K 9 month − 6-K 6 month · filed 2026-01-22 | $58.62K 6-K · filed 2026-01-22 | |||
| 2024-06-30 | $58.62K 6-K · filed 2025-10-08 | ||||
| 2023-12-31 | $624.77K S-4/A · filed 2026-05-11 | ||||
| 2023-06-30 | $558.78K 6-K · filed 2024-12-20 | ||||
| 2022-12-31 | $2.44M 6-K · filed 2025-10-08 | ||||
| 2022-06-30 | $2.71M 6-K · filed 2023-12-22 | ||||
| 2021-12-31 | $16.51M 20-F · filed 2024-04-30 | ||||
| 2021-06-30 | $19.99M 6-K · filed 2022-09-30 | ||||
| 2020-12-31 | $1.84M 20-F · filed 2023-04-28 | ||||
| 2020-06-30 | $898.64K 6-K · filed 2021-09-15 | ||||
| 2019-12-31 | -$108.06K 20-F/A · filed 2023-01-17 | ||||
| 2019-06-30 | -$678.57K 6-K · filed 2020-09-02 | ||||
| 2018-12-31 | -$6.06M 20-F · filed 2021-04-19 | ||||
| 2017-12-31 | $12.80M 20-F · filed 2020-04-29 |